Find Finerenone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1050477-31-0, Kerendia, Bay 94-8862, Bay94-8862, Finerenone (bay 94-8862), (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
Molecular Formula
C21H22N4O3
Molecular Weight
378.4  g/mol
InChI Key
BTBHLEZXCOBLCY-QGZVFWFLSA-N
FDA UNII
DE2O63YV8R

Finerenone
Finerenone, or BAY 94-8862, is a mineralocorticoid receptor antagonist indicated to reduce the risk of sustained decline in glomerular filtration rate, end stage kidney disease, cardiovascular death, heart attacks, and hospitalization due to heart failure in adults with chronic kidney disease associated with type II diabetes mellitus. Patients with kidney disease, would originally be given [spironolactone] or [eplerenone] to antagonize the mineraclocorticoid receptor. Spironolactone has low selectivity and affinity for the receptor; it dissociates quickly and can also have effects at the androgen, progesterone, and glucocorticoid receptors. Eplerenone is more selective and has longer lasting effects. More selective nonsteroidal mineralocorticoid antagonists such as [apararenone], [esaxerenone], and finerenone were later developed. So far, finerenone is the only nonsteroidal mineralocorticoid receptor antagonist to be FDA approved. Finerenone was granted FDA approval on 9 July 2021.
Finerenone is a Nonsteroidal Mineralocorticoid-Receptor Antagonist. The mechanism of action of finerenone is as a Mineralocorticoid Receptor Antagonist.
1 2D Structure

Finerenone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
2.1.2 InChI
InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1
2.1.3 InChI Key
BTBHLEZXCOBLCY-QGZVFWFLSA-N
2.1.4 Canonical SMILES
CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C
2.1.5 Isomeric SMILES
CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C
2.2 Other Identifiers
2.2.1 UNII
DE2O63YV8R
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bay 94-8862

2. Kerendia

2.3.2 Depositor-Supplied Synonyms

1. 1050477-31-0

2. Kerendia

3. Bay 94-8862

4. Bay94-8862

5. Finerenone (bay 94-8862)

6. (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide

7. Bay-94-8862

8. De2o63yv8r

9. 1,6-naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4s)-

10. Finerenone [usan:inn]

11. Unii-de2o63yv8r

12. Finerenone [inn]

13. Finerenone [jan]

14. Finerenone [usan]

15. Finerenone [who-dd]

16. Finerenone (jan/usan/inn)

17. Gtpl8678

18. Schembl8157011

19. Finerenone [orange Book]

20. Amy9115

21. Dtxsid10146928

22. Bcp24177

23. Ex-a2845

24. Bay948862

25. Bay 948862

26. Bay-948862

27. Ac-30916

28. Hy-111372

29. Cs-0040097

30. J3.584.878i

31. D10633

32. F53302

33. Q21099046

34. Bay94-8862; Bay 94-8862; Bay-94-8862; Bay948862; Bay 948862; Bay-948862

2.4 Create Date
2012-09-10
3 Chemical and Physical Properties
Molecular Weight 378.4 g/mol
Molecular Formula C21H22N4O3
XLogP32.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass378.16919058 g/mol
Monoisotopic Mass378.16919058 g/mol
Topological Polar Surface Area110 Ų
Heavy Atom Count28
Formal Charge0
Complexity670
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Finerenone is indicated to reduce the risk of sustained decline in glomerular filtration rate, end stage kidney disease, cardiovascular death, heart attacks, and hospitalization due to heart failure in adults with chronic kidney disease associated with type II diabetes mellitus.


Kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.


Treatment of chronic kidney disease


Treatment of heart failure


5 Pharmacology and Biochemistry
5.1 Pharmacology

Finerenone is a non-steroidal mineralocorticoid receptor antagonist indicated to reduce the risk of sustained decline in glomerular filtration rate, end stage kidney disease, cardiovascular death, heart attacks, and hospitalization due to heart failure in adults with chronic kidney disease associated with type II diabetes mellitus. It has a moderate duration of action as it is taken once daily, and a wide therapeutic window as patients were given doses from 1.25 mg to 80 mg in clinical trials. Patients should be counselled regarding the risk of hyperkalemia.


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
FINERENONE
5.2.2 FDA UNII
DE2O63YV8R
5.2.3 Pharmacological Classes
Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]; Mineralocorticoid Receptor Antagonists [MoA]
5.3 ATC Code

C09


C - Cardiovascular system

C03 - Diuretics

C03D - Aldosterone antagonists and other potassium-sparing agents

C03DA - Aldosterone antagonists

C03DA05 - Finerenone


5.4 Absorption, Distribution and Excretion

Absorption

A 10 mg oral dose of finerenone reaches a Cmax of 351 g/L, with a Tmax of 1.5 hours, and an AUC of 2820 g\*h/L in plasma. The same dose of finerenone reaches a Cmax of 226 g/L, with a Tmax of 1.5 hours, and an AUC of 1840 g\*h/L in whole blood. Regular doses of 20 mg of finerenone reach a geometric mean steady state Cmax of 160 g/L with an AUC of 686 g\*h/L.


Route of Elimination

The majority of the dose recovered in urine was in the form of the M2, M3 (47.8%), and M4 metabolites; <1.3% of the dose recovered in the urine was as the unchanged parent compound. The majority of the dose recovered in the feces was as the M5 metabolite, with only 0.2% eliminated as the unchanged parent compound. The M1 metabolite made up <1.5% of the recovered dose in urine and feces. Finerenone is not expected to be metabolized by the intestinal microflora.


Volume of Distribution

The volume of distribution of finerenone as steady state is 52.6L.


Clearance

The systemic clearance of finerenone is approximately 25 L/h.


5.5 Metabolism/Metabolites

Finerenone is approximately 90% metabolized by CYP3A4, and 10% metabolized by CYP2C8. There is a minor contribution to metabolism by CYP1A1. Finerenone has no active metabolites. Finerenone is aromatized to the M1 metabolite by CYP3A4 and CYP2C8, which is further hydroxylated by CYP3A4 to the M2 metabolite, and finally oxidized bye CYP3A4 to the M3 metabolite. Alternatively, finerenone can undergo epoxidation and possibly hydrolysis by CYP3A4 and CYP2C8 to form the M4 metabolite, which is hydroxylated again by CYP3A4 to the M5 metabolite, and oxidized to the M8 metabolite. Finerenone can also be hydroxylated by CYP2C8 to the M7 metabolite, and further oxidized to the M9 metabolite. The M10 metabolite is formed by the demethylation, oxidation, and ring opening of finerenone. The M13 metabolite is formed through de-ethylation of finerenone by CYP1A1, and the M14 metabolite is formed through an undefined multi-step process involving CYP2C8 and CYP3A4.


5.6 Biological Half-Life

The half life of a 10 mg dose of finerenone in 4 healthy men was 17.4 hours in plasma and 12.3 hours in whole blood. The terminal half life of finerenone is approximately 2-3 hours.


5.7 Mechanism of Action

Finerenone is a non-steroidal selective mineralocorticoid receptor (MR) antagonist with no significant affinity or activity at androgen, progesterone, estrogen, and glucocorticoid receptors. Animal studies have shown that finerenone binding to the MR reduces inflammation and fibrosis, and phase 2 clinical trials showed a reduction in albuminuria. Aldosterone is a mineralocorticoid hormone involved in the regulation of blood pressure, sodium reabsorption, and potassium excretion. In 1943, agonism of the MR along with increased salt was shown to be associated with malignant hypertension, which could progress to inflammation and fibrosis of organs. Binding of aldosterone, an MR agonist, to the MR causes a conformational change, which dissociates the receptor from inactivating chaperone proteins. The active MR translocates to the nucleus along with a complex of other coactivators to induce transcription of a number of genes. Finerenone's binding to the MR prevents binding of MR coactivators, which in turn prevents pro-inflammatory and pro-fibrotic gene transcription. Clinical trial data shows that blocking the mineralocorticoid receptor reduces mortality and morbidity in patients with chronic severe congestive heart failure with an ejection fraction 35%. Patients taking finerenone developed new onset atrial fibrillation or flutter (AFF) with a hazard ratio of 0.71. Finerenone lowered the risk of first onset of kidney failure, a sustained eGFR decrease of 40%, or death from a renal cause to a hazard ratio of 0.82. Cardiovascular outcomes including cardiovascular death, nonfatal heart attacks, nonfatal strokes, and hospitalization for heart failure in patients taking finerenone had a hazard ratio of 0.86 in patients with a history of AFF and 0.85 in patients without a history of AFF.


API SUPPLIERS

read-more
read-more

01

Shandong Chenghui Shuangda Pharmac...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChina's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shandong Chenghui Shuangda Pharmaceutical

02

Ami Lifesciences Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
AMI Lifesciences

03

Minakem

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Minakem Comapny Banner

04

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

05

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

06

Jinan Tantu Chemicals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jinan Tantu Chemicals

07

Shandong Loncom Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shandong Loncom Pharmaceutical company banner

08

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

09

Ami Lifesciences Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
AMI Lifesciences

10

Lee Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CRS
Not Confirmed
arrow

Lee Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CRS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38889

Submission : 2023-09-28

Status : Active

Type : II

AMI Lifesciences

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41232

Submission : 2025-02-25

Status : Active

Type : II

AMI Lifesciences

03

APGA Annual Conference
Not Confirmed

03

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2024-12-13

Pay. Date : 2024-11-12

DMF Number : 40497

Submission : 2024-10-29

Status : Active

Type : II

blank

04

APGA Annual Conference
Not Confirmed

04

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-04-23

Pay. Date : 2025-03-27

DMF Number : 39888

Submission : 2024-05-03

Status : Active

Type : II

blank

05

APGA Annual Conference
Not Confirmed

05

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-02-18

Pay. Date : 2024-12-23

DMF Number : 40906

Submission : 2024-12-06

Status : Active

Type : II

blank

06

APGA Annual Conference
Not Confirmed

06

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40501

Submission : 2024-09-28

Status : Active

Type : II

blank

08

APGA Annual Conference
Not Confirmed

08

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-01-28

Pay. Date : 2024-12-30

DMF Number : 40504

Submission : 2024-09-27

Status : Active

Type : II

blank

09

APGA Annual Conference
Not Confirmed

09

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40263

Submission : 2024-08-31

Status : Active

Type : II

blank

10

APGA Annual Conference
Not Confirmed

10

APGA Annual Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-01-28

Pay. Date : 2025-01-22

DMF Number : 41150

Submission : 2025-01-10

Status : Active

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Bayer AG

Germany
APGA Annual Conference
Not Confirmed
arrow

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Finerenone

Registrant Name : Bayer Korea Ltd.

Registration Date : 2022-05-10

Registration Number : Su212-9-ND

Manufacturer Name : Bayer AG@Bayer AG@Bayer AG

Manufacturer Address : Friedrich-Ebert-Str. 217-333, 42117 Wuppertal, Germany@Kaiser-Wilhelm-Allee 51368 Lev...

blank

02

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Finerenone

Registrant Name : Sampoong Pharmachem Co., Ltd.

Registration Date : 2025-05-16

Registration Number : No. 582-32-ND

Manufacturer Name : Zenji Pharmaceuticals (Suzho...

Manufacturer Address : No. 122, Xuqing Road, Xuguan Town

blank

03

APGA Annual Conference
Not Confirmed
arrow

arrow
APGA Annual Conference
Not Confirmed

Finerenone

Registrant Name : Otran Korea Co., Ltd.

Registration Date : 2025-06-26

Registration Number : No. 6199-5-ND

Manufacturer Name : Nantong Chanyoo Pharmatech C...

Manufacturer Address : No. 2 Tonghai Si Road, Yangkou Chemical Industrial Park, Rudong Coastal Economic Deve...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

FINERENONE

NDC Package Code : 50683-0540

Start Marketing Date : 2022-04-08

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

FINERENONE

NDC Package Code : 72640-032

Start Marketing Date : 2025-01-10

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

Maithri Drugs Private Limited

Country
APGA Annual Conference
Not Confirmed
arrow

Maithri Drugs Private Limited

Country
arrow
APGA Annual Conference
Not Confirmed

FINERENONE

NDC Package Code : 70600-059

Start Marketing Date : 2024-08-15

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChina's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.

Flag China
Digital Content Digital Content

Finerenone

About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is specialized in R&D and production of APIs and advanced intermediates. With 22 years of production experience,the company has ...

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is specialized in R&D and production of APIs and advanced intermediates. With 22 years of production experience,the company has 6 workshops and 9 production lines which has 100t/month production capacity.The company is committed to maintain the standards with continuous improvements to the current standards throughout the product lifecycle.The main products include local anesthetic drugs, antiviral drugs, cardiovascular and cerebrovascular drugs, antitumor drugs, gastrointestinal drugs, diabetic drugs, veterinary drugs, and CDMO products.
Shandong Chenghui Shuangda Pharmaceutical

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

Finerenone

About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...

Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory therapeutic areas, Ami offers a wide range of APIs, intermediates, key starting materials, as well as contract bulk manufacturing services. Ami's manufacturing units in Gujarat and Karnataka feature dedicated clean rooms for APIs and adhere to international standards like EU-GMP, WHO-GMP, PMDA, and COFEPRIS. Ami serves as a reliable partner for contract development and manufacturing, offering generic APIs to global pharma companies across more than 60 countries.
AMI Lifesciences

03

Minakem

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

Finerenone

About the Company : MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&D teams, supported b...

MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&D teams, supported by strong analytical and regulatory affairs services. The R&D team has an expertise in process development, organic synthesis, and works under a secrecy agreement to protect your IP. With 3 production sites in Europe and 1 in Canada, Minakem is ready to support your strategic sourcing projects or your reshoring activities. Recently launched commercial generic API: Apixaban, Mirabegron, Fulvestrant, remifentanil, esmolol,
Minakem Comapny Banner

04

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Finerenone

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Finerenone

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content

Finerenone

About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...

Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include customized R&D as well as the production of small molecule pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) for both international and domestic pharmaceutical firms. Our capabilities span from laboratory-scale kilograms to commercial ton-scale production. Additionally, we are committed to independent research and development, as well as the production and sales of high-end pharmaceutical intermediates and API products.
Jinan Tantu Chemicals

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.

Flag China
Digital Content Digital Content

Finerenone

About the Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe Economic Development...

Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe Economic Development Zone, Shandong Province, Shandong Loncom has operational API pilot tests and production bases adhering to international standards. With 13 production lines dedicated to oral solid preparations, oral liquid preparations and API, it is actively expanding its preparation workshops for small-volume injections, soft capsules, eye drops, topical medicines and innovative drug R&D centres.
Shandong Loncom Pharmaceutical company banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Finerenone

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry with over 350 Products portfolio. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.
TAPI Company Banner

09

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Finerenone

About the Company : Guangzhou Topwork Chemical Co., Ltd. Specializes in manufacturing corticosteroid and relative intermediates. We provide high quality products and excellent service to our clients a...

Guangzhou Topwork Chemical Co., Ltd. Specializes in manufacturing corticosteroid and relative intermediates. We provide high quality products and excellent service to our clients and have gained a high business reputation in the world market. Topwork gathers a group of energetic, hardworking and much experienced experts. They dedicate their entire efforts to research and development of new products. To guarantee the quality of our products, we have established an international standard quality control system. All of our products conform the latest standard of USP, EP, BP and CP.
blank

10

Nifty Labs

India
APGA Annual Conference
Not Confirmed
arrow

Nifty Labs

India
arrow
APGA Annual Conference
Not Confirmed

Finerenone

About the Company : The company was founded by a technocrat Mr. D. Kesava Reddy in the year 2005. The Managing Director Mr. D. Kesava Reddy along with other three Board of Directors involved in contro...

The company was founded by a technocrat Mr. D. Kesava Reddy in the year 2005. The Managing Director Mr. D. Kesava Reddy along with other three Board of Directors involved in controlling the day to day operations of the company. The company has been focused on manufacturing and marketing of Bulk APIs (Bulk Drugs) and key Intermediates for APIs for Domestic and Global markets. About 60% is catered to domestic market and the rest 40% is catered to exports. The company does have a sister company named “Nifty Pharma Pvt. Ltd. located in Hyderabad focused on manufacturing & marketing of Semi-finished dosage forms.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1671906600,"product":"FINERENONE IH BATCH. NO. FIN\/RD\/62741122","address":"2ND FLOOR, PRESTIGE PLAZA, 40 URMI NEAR URMI CROSSING, BPC ROAD, AKOTA","city":"VADODARA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"GLOBAL NAPI PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"0.06","actualQuantity":"0.06","unit":"KGS","unitRateFc":"75000","totalValueFC":"4465.7","currency":"USD","unitRateINR":6133333.333333334,"date":"25-Dec-2022","totalValueINR":"368000","totalValueInUsd":"4465.7","indian_port":"AHMEDABAD AIR","hs_no":"29339990","bill_no":"6428558","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"2ND FLOOR, PRESTIGE PLAZA, 40 URMI NEAR URMI CROSSING, BPC ROAD, AKOTA, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1671906600,"product":"FINERENONE IH BATCH. NO. FIN\/RD\/62741122","address":"2ND FLOOR, PRESTIGE PLAZA, 40 URMI NEAR URMI CROSSING, BPC ROAD, AKOTA","city":"VADODARA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"GLOBAL NAPI PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"0.06","actualQuantity":"0.06","unit":"KGS","unitRateFc":"75000","totalValueFC":"4465.7","currency":"USD","unitRateINR":6133333.333333334,"date":"25-Dec-2022","totalValueINR":"368000","totalValueInUsd":"4465.7","indian_port":"AHMEDABAD AIR","hs_no":"29339990","bill_no":"6428571","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"2ND FLOOR, PRESTIGE PLAZA, 40 URMI NEAR URMI CROSSING, BPC ROAD, AKOTA, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672079400,"product":"FINERENONE IH BATCH NO-FIN\/RD\/61350822 M","address":"2ND FLOOR, PRESTIGE PLAZA, 40 URMI NEAR URMI CROSSING, BPC ROAD, AKOTA","city":"VADODARA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"LIPTIS FOR PHARMACEUTICALS MEDICA","customerCountry":"EGYPT","quantity":"0.09","actualQuantity":"0.09","unit":"KGS","unitRateFc":"65000","totalValueFC":"5812.7","currency":"USD","unitRateINR":5322222.222222222,"date":"27-Dec-2022","totalValueINR":"479000","totalValueInUsd":"5812.7","indian_port":"AHMEDABAD AIR","hs_no":"29339990","bill_no":"6460997","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"2ND FLOOR, PRESTIGE PLAZA, 40 URMI NEAR URMI CROSSING, BPC ROAD, AKOTA, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694975400,"product":"PHARMACEUTICAL RAW MATERIAL-FINERENONE IH, BATCH NO.FIN\/60020723","address":"277\/2,BHAVESHWAR VILLA,RD.NO.31,","city":"MUMBAI,MAHARASHTRA","supplier":"SANJAY CHEMICALS","supplierCountry":"INDIA","foreign_port":"NAIROBI","customer":"UNDISCLOSED","customerCountry":"KENYA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"27","totalValueFC":"13372.2","currency":"USD","unitRateINR":2220,"date":"18-Sep-2023","totalValueINR":"1110000","totalValueInUsd":"13372.2","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"3999819","productDescription":"API","marketType":"","country":"KENYA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"277\/2,BHAVESHWAR VILLA,RD.NO.31,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698863400,"product":"WE HEREBY DECLARE TO CLAIM REWARDS UNDER RODTEP ,FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"N\/A","customer":"UNDISCLOSED","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.30","actualQuantity":"300","unit":"GMS","unitRateFc":"22500","totalValueFC":"6634","currency":"USD","unitRateINR":1841.3833333333334,"date":"02-Nov-2023","totalValueINR":"552415","totalValueInUsd":"6634","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"5092856","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA, REPULIC","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700245800,"product":"FINERENONE IH-AS PER INVOICE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU TOSUN PHARMACEUTICAL LTD","customerCountry":"CHINA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"7000","totalValueFC":"3458.6","currency":"USD","unitRateINR":576000,"date":"18-Nov-2023","totalValueINR":"288000","totalValueInUsd":"3458.6","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"5409761","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709577000,"product":"FINERENONE","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"MERKO PHARMACEUTICAL CHEMICAL","customerCountry":"TURKEY","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"25000","totalValueFC":"26278.6","currency":"EURO","unitRateINR":2182068,"date":"05-Mar-2024","totalValueINR":"2182068","totalValueInUsd":"26278.6","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8067306","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710786600,"product":"PHARMACEUTICAL RAW MATERIAL AS PERPO NO. 202305-165 FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"TUNIS","customer":"TUNISIA","customerCountry":"TUNISIA","quantity":"0.16","actualQuantity":"0.16","unit":"KGS","unitRateFc":"25000","totalValueFC":"3859.6","currency":"USD","unitRateINR":2003030.1875,"date":"19-Mar-2024","totalValueINR":"320484.83","totalValueInUsd":"3859.6","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"8461475","productDescription":"API","marketType":"","country":"TUNISIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712169000,"product":"FINERENONE","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"WATSON PHARMA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"15","totalValueFC":"7456","currency":"USD","unitRateINR":1245.2650000000001,"date":"04-Apr-2024","totalValueINR":"622632.5","totalValueInUsd":"7456","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"8883276","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"21-22, KALPATARU SQUARE, KONDIVITA, ANDHERI (E), MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713810600,"product":"FINERENONE","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"WATSON PHARMA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"15.2","totalValueFC":"7496.8","currency":"USD","unitRateINR":1252.078,"date":"23-Apr-2024","totalValueINR":"626039","totalValueInUsd":"7496.8","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"9336635","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"21-22, KALPATARU SQUARE, KONDIVITA, ANDHERI (E), MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713983400,"product":"FINERENONE - CONTROL BATCH NO 1108000124MFG DT.APRIL 2024 RETEST DT. APRIL 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"37090.3","currency":"USD","unitRateINR":1548653.7949999999,"date":"25-Apr-2024","totalValueINR":"3097307.59","totalValueInUsd":"37090.3","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"9370106","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713983400,"product":"FINERENONE - CONTROL BATCH NO 1108000224MFG DT.APRIL 2024 RETEST DT. APRIL 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"36960.9","currency":"USD","unitRateINR":1543251.7949999999,"date":"25-Apr-2024","totalValueINR":"3086503.59","totalValueInUsd":"36960.9","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"9370102","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723746600,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32518001822 DT. 09.08.2024 FINERENONE","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK LIFE SCIENCES LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"UNDISCLOSED","customerCountry":"TURKEY","quantity":"1.56","actualQuantity":"1.56","unit":"KGS","unitRateFc":"15000","totalValueFC":"23036.6","currency":"USD","unitRateINR":1238637.4615384615,"date":"16-Aug-2024","totalValueINR":"1932274.44","totalValueInUsd":"23036.6","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"3238113","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723833000,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"BIRATNAGAR","customer":"ALIVE PHARMACEUTICALS PVT LTD","customerCountry":"NEPAL","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"700000","totalValueFC":"4172.7","currency":"INR","unitRateINR":700000,"date":"17-Aug-2024","totalValueINR":"350000","totalValueInUsd":"4172.7","indian_port":"Jogbani","hs_no":"29339990","bill_no":"3272457","productDescription":"API","marketType":"","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Jogbani","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724697000,"product":"PHARMACEUTICAL RAW MATERIAL FOR MFG OF INTERMEDIATE BULK DRUG- FINERENONE CAS NO.1050477-31-0","address":"SHED NO F-1, IDA, ROAD NO.6","city":"KUKATPALLY","supplier":"VIRUJ CHEMATRIX PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"EL QAHIRA (= CAIRO)","customer":"BANK MISR","customerCountry":"EGYPT","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"5000","totalValueFC":"98031.6","currency":"USD","unitRateINR":411137.25,"date":"27-Aug-2024","totalValueINR":"8222745","totalValueInUsd":"98031.6","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29349990","bill_no":"3522968","productDescription":"Intermediate","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"JNPT SEZ\/MUMBAI","supplierAddress":"SHED NO F-1, IDA, ROAD NO.6, KUKATPALLY","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"FINERENONE - CONTROL BATCH NO 1108000324MFG DT.AUGUST 2024 RETEST DT. AUGUST 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"7.25","actualQuantity":"7.25","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"134369.9","currency":"USD","unitRateINR":1553153.6772413794,"date":"02-Sep-2024","totalValueINR":"11260364.16","totalValueInUsd":"134369.9","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"3681566","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"FINERENONE - CONTROL BATCH NO 1108000424MFG DT.AUGUST 2024 RETEST DT. AUGUST 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"7.25","actualQuantity":"7.25","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"134369.9","currency":"USD","unitRateINR":1553153.6772413794,"date":"02-Sep-2024","totalValueINR":"11260364.16","totalValueInUsd":"134369.9","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"3681566","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727375400,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API) EXPORT INVOICE NUMBER : F32518002400 DT. 25.09.2024 FINERENONE","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK LIFE SCIENCES LTD","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"UNDISCLOSED","customerCountry":"ARGENTINA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"15000","totalValueFC":"74029.1","currency":"USD","unitRateINR":1240746.25,"date":"27-Sep-2024","totalValueINR":"6203731.25","totalValueInUsd":"74029.1","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"4402927","productDescription":"API","marketType":"","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728066600,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"TUNIS","customer":"TUNISIA","customerCountry":"TUNISIA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"23000","totalValueFC":"4450.4","currency":"USD","unitRateINR":1869750,"date":"05-Oct-2024","totalValueINR":"373950","totalValueInUsd":"4450.4","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"4612531","productDescription":"API","marketType":"","country":"TUNISIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729189800,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API) EXPORT INVOICE NUMBER : F32518002766 DT. 15.10.2024 FINERENONE","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK LIFE SCIENCES LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"UNDISCLOSED","customerCountry":"TURKEY","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"15000","totalValueFC":"7249.3","currency":"USD","unitRateINR":1218271.74,"date":"18-Oct-2024","totalValueINR":"609135.87","totalValueInUsd":"7249.3","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"4927657","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729967400,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"BIRGUNJ","customer":"SRDRUG LABORATORIES PVT LTD","customerCountry":"NEPAL","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"750000","totalValueFC":"446.3","currency":"INR","unitRateINR":750000,"date":"27-Oct-2024","totalValueINR":"37500","totalValueInUsd":"446.3","indian_port":"Raxaul","hs_no":"29339990","bill_no":"5184867","productDescription":"API","marketType":"","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Raxaul","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731695400,"product":"FINERENONE- CONTROL BATCH NO 1108000524MFG DT.APRIL 2024 RETEST DT. APRIL 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"1.67","actualQuantity":"1.672","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"30992","currency":"USD","unitRateINR":1564208.4330143542,"date":"16-Nov-2024","totalValueINR":"2615356.5","totalValueInUsd":"30992","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"5657585","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731695400,"product":"FINERENONE- CONTROL BATCH NO 1108000624MFG DT.NOVEMBER 2024 RETEST DT. NOVEMBER 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"9.38","actualQuantity":"9.376","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"173792.3","currency":"USD","unitRateINR":1564208.0268771334,"date":"16-Nov-2024","totalValueINR":"14666014.46","totalValueInUsd":"173792.3","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"5657585","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731695400,"product":"FINERENONE- CONTROL BATCH NO 1108000724MFG DT.NOVEMBER 2024 RETEST DT.NOVEMBER2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TEVA CANADA LTD","customerCountry":"CANADA","quantity":"7.45","actualQuantity":"7.452","unit":"KGS","unitRateFc":"18736.2","totalValueFC":"138129.3","currency":"USD","unitRateINR":1564208.01798175,"date":"16-Nov-2024","totalValueINR":"11656478.15","totalValueInUsd":"138129.3","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"5657585","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732041000,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"BIRGUNJ","customer":"QUEST PHARMACEUTICALS PVT LTD","customerCountry":"NEPAL","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"650000","totalValueFC":"3851.2","currency":"INR","unitRateINR":649999.93999999994,"date":"20-Nov-2024","totalValueINR":"324999.97","totalValueInUsd":"3851.2","indian_port":"Raxaul","hs_no":"29339990","bill_no":"5759845","productDescription":"API","marketType":"","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Raxaul","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733164200,"product":"PHARAMACEUTICALS RAW MATERIAL ( FINERENONE IH )","address":"FLAT NO.301 PLOT NO A 68,SECTOR 10","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"ASTER INTERNATIONAL PHARMACEUTICALS LLP","supplierCountry":"INDIA","foreign_port":"BHAIRAWA","customer":"ASIAN PHARMACEUTICALS PVT LTD","customerCountry":"NEPAL","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"2500","totalValueFC":"2942.3","currency":"INR","unitRateINR":2500,"date":"03-Dec-2024","totalValueINR":"250000","totalValueInUsd":"2942.3","indian_port":"Sonauli","hs_no":"29349990","bill_no":"6131794","productDescription":"API","marketType":"","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Sonauli","supplierAddress":"FLAT NO.301 PLOT NO A 68,SECTOR 10, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733855400,"product":"FINERENONE IH","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"TUNIS","customer":"OPALIA PHARMA S A ZI","customerCountry":"TUNISIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"25000","totalValueFC":"12341.8","currency":"USD","unitRateINR":2097332.2000000002,"date":"11-Dec-2024","totalValueINR":"1048666.1","totalValueInUsd":"12341.8","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"6354840","productDescription":"API","marketType":"","country":"TUNISIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734028200,"product":"FINERENONE (EXPORT INVOICE NO:6124010516DT:10.12.2024)","address":"SYNO.257 258\/1, DNO.11-6\/56,","city":"VILLAGE BALANGAR POST HYDERABAD","supplier":"LEE PHARMA LTD","supplierCountry":"INDIA","foreign_port":"WARSAW","customer":"ADAMED PHARMA S A","customerCountry":"POLAND","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"12000","totalValueFC":"5785.2","currency":"USD","unitRateINR":983118,"date":"13-Dec-2024","totalValueINR":"491559","totalValueInUsd":"5785.2","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6413090","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SYNO.257 258\/1, DNO.11-6\/56,, VILLAGE BALANGAR POST HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734633000,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API)EXPORT INVOICE NUMBER : F32518003739 DT. 17.12.2024 FINERENONE","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"GLENMARK LIFE SCIENCES LTD","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"UNDISCLOSED","customerCountry":"KOREA, REPUBLIC OF","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"14955.8","totalValueFC":"14829.3","currency":"USD","unitRateINR":1260027.8400000001,"date":"20-Dec-2024","totalValueINR":"1260027.84","totalValueInUsd":"14829.3","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"6610348","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1736361000,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"UNDISCLOSED","customerCountry":"EGYPT","quantity":"13.00","actualQuantity":"13","unit":"KGS","unitRateFc":"5100","totalValueFC":"65161.5","currency":"USD","unitRateINR":432217.2792307692,"date":"09-Jan-2025","totalValueINR":"5618824.63","totalValueInUsd":"65161.5","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"7165627","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1736447400,"product":"FINERENONE AS INVOICE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"SEOUL","customer":"HANSOL PHARMA CO LTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.05","actualQuantity":"0.052","unit":"KGS","unitRateFc":"55000","totalValueFC":"2781.5","currency":"USD","unitRateINR":4612355.769230769,"date":"10-Jan-2025","totalValueINR":"239842.5","totalValueInUsd":"2781.5","indian_port":"Ahmedabad Air","hs_no":"29333990","bill_no":"7184743","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1738521000,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (API) EXPORT INVOICE NUMBER : F32518004568 DT. 31.01.2025 FINERENONE","address":"PLOT 170-172, CHANDRAMOULI,INDUSTR","city":"SOLAPUR,MAHARASHTRA","supplier":"ALIVUS LIFE SCIENCES LTD","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"UNDISCLOSED","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"15000","totalValueFC":"2896.8","currency":"USD","unitRateINR":1259580,"date":"03-Feb-2025","totalValueINR":"251916","totalValueInUsd":"2896.8","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"7858280","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT 170-172, CHANDRAMOULI,INDUSTR, SOLAPUR,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741026600,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"TUNIS","customer":"UNDISCLOSED","customerCountry":"TUNISIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"25000","totalValueFC":"12330.4","currency":"USD","unitRateINR":2136067.3399999999,"date":"04-Mar-2025","totalValueINR":"1068033.67","totalValueInUsd":"12330.4","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"8696010","productDescription":"API","marketType":"","country":"TUNISIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741804200,"product":"FINERENONE","address":"PLOT NO.C-24, MNS HOUSE,","city":"HYDERABAD, AP.","supplier":"MAITHRI DRUGS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"TRANZONE FZE","customerCountry":"UNITED ARAB EMIRATES","quantity":"13.00","actualQuantity":"13","unit":"KGS","unitRateFc":"8000","totalValueFC":"103316.9","currency":"USD","unitRateINR":688389.23076923075,"date":"13-Mar-2025","totalValueINR":"8949060","totalValueInUsd":"103316.9","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8978347","productDescription":"API","marketType":"","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MNS HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743705000,"product":"FINERENONE IH","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"BANGKOK","customer":"THAILAND","customerCountry":"THAILAND","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"10165","totalValueFC":"19667.4","currency":"USD","unitRateINR":841783.5,"date":"04-Apr-2025","totalValueINR":"1683567","totalValueInUsd":"19667.4","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"9662895","productDescription":"API","marketType":"","country":"THAILAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746124200,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"LISBON","customer":"UNDISCLOSED","customerCountry":"PORTUGAL","quantity":"0.75","actualQuantity":"0.75","unit":"KGS","unitRateFc":"12000","totalValueFC":"9708.8","currency":"EUR","unitRateINR":1102933.3333333333,"date":"02-May-2025","totalValueINR":"827200","totalValueInUsd":"9708.8","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"1459124","productDescription":"API","marketType":"REGULATED MARKET","country":"PORTUGAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746469800,"product":"FINERENONE","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PVT LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"UNDISCLOSED","customerCountry":"TURKEY","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"9000","totalValueFC":"35281.7","currency":"USD","unitRateINR":751505.625,"date":"06-May-2025","totalValueINR":"3006022.5","totalValueInUsd":"35281.7","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"1564222","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681065000,"product":"FINERENONE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.75","actualQuantity":"0.75","unit":"KGS","unitRateFc":"15000","totalValueFC":"11373","currency":"USD","unitRateINR":"1242750","date":"10-Apr-2023","totalValueINR":"932062.5","totalValueInUsd":"11373","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"5454542","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693161000,"product":"PHARMACEUTICAL RAW MATERIAL FOR MFG OF INTERMEDIATE BULK DRUG- FINERENONE CAS NO.1050477-31-0","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"HANGZHOU QICHUANG CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"VIRUJ PHARMACEUTICALS PRIVATE LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"6400","totalValueFC":"6482.2","currency":"USD","unitRateINR":"536960","date":"28-Aug-2023","totalValueINR":"536960","totalValueInUsd":"6482.2","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29349990","bill_no":"1015002","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"ROOM 1204, NINGBO MANSION, NO.46,TIANMUSHAN ROAD, XIHU DISTRICT,HANGZHOU, CHINA CN","customerAddress":"B-4, IDA,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695925800,"product":"FINERENONE IUPAC NAME:(4S)-4-4(4-CYANO-2-METHOXYPHENYL)-5 INDINE-3-CARBOXAMIDE","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"AURISCO PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"WATSON PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"15000","totalValueFC":"30376.5","currency":"USD","unitRateINR":"1260750","date":"29-Sep-2023","totalValueINR":"2521500","totalValueInUsd":"30376.5","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"8071730","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"BADU INDUSTRIAL PARK ZONE TIANTAI,ZHEJIANG PROVINCE 317200 ZHEJIANG,, China China","customerAddress":"21-22, KALPATARU SQUARE, KONDIVITA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704652200,"product":"FINERENONE (IUPAC NAME: (4S)-4-(4-CY AN0-2-METHOXYPHENYT)-5-ETHOXY-2,8-DIMETHYL-L,4-DIHYDRO-L,6-NAPHTH!YR) QTY: 0.9 KGS","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING COLI MITED","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.90","actualQuantity":"0.9","unit":"KGS","unitRateFc":"15000","totalValueFC":"13684.9","currency":"USD","unitRateINR":"1263750","date":"08-Jan-2024","totalValueINR":"1137375","totalValueInUsd":"13684.9","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"9570194","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D10\/FTOWER A BILLION CTR1 WANG KWONG RD KOWLOON BAY KL,HONGCHINA CN","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706639400,"product":"FINERENONE","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"AURISCO PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"WATSON PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"15000","totalValueFC":"15178.4","currency":"USD","unitRateINR":"1261500","date":"31-Jan-2024","totalValueINR":"1261500","totalValueInUsd":"15178.4","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"9923113","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"BADU INDUSTRIAL PARK ZONE TIANTAI,ZHEJIANG PROVINCE 317200 ZHEJIANG,, China China","customerAddress":"21-22, KALPATARU SQUARE, KONDIVITA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710095400,"product":"(FOC) FINERENONE","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"AURISCO PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"WATSON PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"15000","totalValueFC":"15129","currency":"USD","unitRateINR":"1256250","date":"11-Mar-2024","totalValueINR":"1256250","totalValueInUsd":"15129","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2524776","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"BADU INDUSTRIAL PARK ZONE TIANTAI,ZHEJIANG PROVINCE 317200 ZHEJIANG,, China China","customerAddress":"21-22, KALPATARU SQUARE, KONDIVITA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720549800,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYR (QTY:500 GMS, VALUE:USD 4750)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"9500","totalValueFC":"4798.8","currency":"USD","unitRateINR":"802275","date":"10-Jul-2024","totalValueINR":"401137.5","totalValueInUsd":"4798.8","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4427308","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WANG KWONG RD KOWLOON BAY KL, HONG KONG, CHINA China China China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720636200,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYR (QTY:500 GMS, VALUE:USD 3900)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"7800","totalValueFC":"3940.1","currency":"USD","unitRateINR":"658710","date":"11-Jul-2024","totalValueINR":"329355","totalValueInUsd":"3940.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4439481","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WANG KWONG RD KOWLOON BAY KL, HONG KONG, CHINA China China China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723573800,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYR (QTY:500 GMS, VALUE:USD 3250)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"6500","totalValueFC":"3278","currency":"USD","unitRateINR":"549900","date":"14-Aug-2024","totalValueINR":"274950","totalValueInUsd":"3278","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5042871","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WANG KWONG RD KOWLOON BAY KL, HONG KONG, CHINA China China China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723833000,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6 (QTY:15.5 KGS, VALUE:USD 112375)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"15.50","actualQuantity":"15.5","unit":"KGS","unitRateFc":"7250","totalValueFC":"113676.5","currency":"USD","unitRateINR":"615162.5","date":"17-Aug-2024","totalValueINR":"9535018.75","totalValueInUsd":"113676.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5112016","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WANG KWONG RD KOWLOON BAY KL, HONG KONG, CHINA China China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725820200,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6 (QTY:500 GMS, VALUE:USD 3900)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"7800","totalValueFC":"3951.1","currency":"USD","unitRateINR":"662220","date":"09-Sep-2024","totalValueINR":"331110","totalValueInUsd":"3951.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5511840","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WAN G KWONG RD KOWLOON BAY KL, HONG KON G, CHINA China China","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727116200,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6 (QTY:1 KGS, VALUE:USD 7250)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"7250","totalValueFC":"7319.1","currency":"USD","unitRateINR":"613350","date":"24-Sep-2024","totalValueINR":"613350","totalValueInUsd":"7319.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5773458","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WAN G KWONG RD KOWLOON BAY KL, HONG KON G, CHINA China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729017000,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6 (QTY:1 KGS, VALUE:USD 7250)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"7250","totalValueFC":"7321","currency":"USD","unitRateINR":"615162.5","date":"16-Oct-2024","totalValueINR":"615162.5","totalValueInUsd":"7321","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6143507","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WAN G KWONG RD KOWLOON BAY KL, HONG KON G, CHINA China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739385000,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6 (QTY:500 GMS, VALUE:USD 3625)FINERENONE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"7250","totalValueFC":"3684.9","currency":"USD","unitRateINR":"640900","date":"13-Feb-2025","totalValueINR":"320450","totalValueInUsd":"3684.9","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"8321600","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WAN G KWONG RD KOWLOON BAY KL, HONG KON G, CHINA China","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"FINERENONE (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6 (QTY:1 KG, VALUE:USD 7250)FINERENONE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HONG KONG AURISCO TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"7250","totalValueFC":"7349","currency":"USD","unitRateINR":"636550","date":"07-Mar-2025","totalValueINR":"636550","totalValueInUsd":"7349","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"8758394","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"RM D 10\/F TOWER A BILLION CTR 1 WAN G KWONG RD KOWLOON BAY KL, HONG KON G, CHINA China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"}]
25-Dec-2022
06-May-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist approved to treat patients with heart failure with left ventricular ejection fraction.


Lead Product(s): Finerenone

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Kerendia

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 15, 2025

blank

01

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist approved to treat patients with heart failure with left ventricular ejection fraction.

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

July 15, 2025

blank

Details:

Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist, being evaluated for heart failure with left ventricular ejection fraction.


Lead Product(s): Finerenone

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 17, 2025

blank

02

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist, being evaluated for heart failure with left ventricular ejection fraction.

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 17, 2025

blank

Details:

Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist, being evaluated for heart failure with mildly reduced or preserved ejection fraction.


Lead Product(s): Finerenone

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 14, 2025

blank

03

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist, being evaluated for heart failure with mildly reduced or preserved ejection fraction.

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 14, 2025

blank

Details:

Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist, being evaluated for heart failure with mildly reduced or preserved ejection fraction.


Lead Product(s): Finerenone

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 08, 2024

blank

04

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist, being evaluated for heart failure with mildly reduced or preserved ejection fraction.

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 08, 2024

blank

Details:

Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor (MR) antagonist that has been shown to block harmful effects of MR overactivation. MR overactivation contributes to CKD progression and cardiovascular damage.


Lead Product(s): Finerenone

Therapeutic Area: Nephrology Brand Name: Kerendia

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 02, 2023

blank

05

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor (MR) antagonist that has been shown to block harmful effects of MR overactivation. MR overactivation contributes to CKD progression and cardiovascular damage.

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 02, 2023

blank

Details:

Kerendia/Firialta (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation and expands clinical development program investigating finerenone for potential treatment of heart failure.


Lead Product(s): Finerenone

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 31, 2023

blank

06

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia/Firialta (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation and expands clinical development program investigating finerenone for potential treatment...

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 31, 2023

blank

Details:

Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation, which is investigating for the treatment of heart failure.


Lead Product(s): Finerenone

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: CPC Clinical Research

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 24, 2023

blank

07

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation, which is investigating for the treatment of heart failure.

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 24, 2023

blank

Details:

Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist and was approved by the FDA to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure.


Lead Product(s): Finerenone

Therapeutic Area: Nephrology Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 22, 2023

blank

08

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist and was approved by the FDA to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization ...

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 22, 2023

blank

Details:

Kerendia/Firialta (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation. It has been granted marketing authorization for expanded indication in China for chronic kidney disease and T2D.


Lead Product(s): Finerenone

Therapeutic Area: Nephrology Brand Name: Kerendia

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 22, 2023

blank

09

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia/Firialta (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation. It has been granted marketing authorization for expanded indication in China for chronic...

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 22, 2023

blank

Details:

Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation. It has been granted marketing authorization for expanded indication in China for chronic kidney disease and T2D.


Lead Product(s): Finerenone

Therapeutic Area: Nephrology Brand Name: Kerendia

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 17, 2023

blank

10

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Bayer AG

Germany
arrow
APGA Annual Conference
Not Confirmed

Details : Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block harmful effects of MR overactivation. It has been granted marketing authorization for expanded indication in China for chronic kidney d...

Product Name : Kerendia

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 17, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

BAYER HLTHCARE

Germany
IFT FIRST
Not Confirmed
arrow

BAYER HLTHCARE

Germany
arrow
IFT FIRST
Not Confirmed

FINERENONE

Brand Name : KERENDIA

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Approval Date : 2021-07-09

Application Number : 215341

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

BAYER HLTHCARE

Germany
IFT FIRST
Not Confirmed
arrow

BAYER HLTHCARE

Germany
arrow
IFT FIRST
Not Confirmed

FINERENONE

Brand Name : KERENDIA

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Approval Date : 2021-07-09

Application Number : 215341

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

CRS
Not Confirmed
arrow
arrow
CRS
Not Confirmed

Finerenonum

Brand Name : Kerendia

Dosage Form : Filmtablet

Dosage Strength : 10mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

CRS
Not Confirmed
arrow
arrow
CRS
Not Confirmed

Finerenonum

Brand Name : Kerendia

Dosage Form : Filmtablet

Dosage Strength : 10mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

CRS
Not Confirmed
arrow
arrow
CRS
Not Confirmed

Finerenonum

Brand Name : Kerendia

Dosage Form : Filmtablet

Dosage Strength : 20mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

CRS
Not Confirmed
arrow
arrow
CRS
Not Confirmed

Finerenonum

Brand Name : Kerendia

Dosage Form : Filmtablet

Dosage Strength : 20mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

BAYER INC

Germany
CRS
Not Confirmed
arrow

BAYER INC

Germany
arrow
CRS
Not Confirmed

FINERENONE

Brand Name : KERENDIA

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2531917

Regulatory Info :

Registration Country : Canada

blank

02

BAYER INC

Germany
CRS
Not Confirmed
arrow

BAYER INC

Germany
arrow
CRS
Not Confirmed

FINERENONE

Brand Name : KERENDIA

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number : 2531925

Regulatory Info :

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 1050477-31-0 / Finerenone API manufacturers, exporters & distributors?

Finerenone manufacturers, exporters & distributors 1

52

PharmaCompass offers a list of Finerenone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Finerenone manufacturer or Finerenone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Finerenone manufacturer or Finerenone supplier.

PharmaCompass also assists you with knowing the Finerenone API Price utilized in the formulation of products. Finerenone API Price is not always fixed or binding as the Finerenone Price is obtained through a variety of data sources. The Finerenone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Finerenone

Synonyms

1050477-31-0, Kerendia, Bay 94-8862, Bay94-8862, Finerenone (bay 94-8862), (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide

Cas Number

1050477-31-0

Unique Ingredient Identifier (UNII)

DE2O63YV8R

About Finerenone

Finerenone, or BAY 94-8862, is a mineralocorticoid receptor antagonist indicated to reduce the risk of sustained decline in glomerular filtration rate, end stage kidney disease, cardiovascular death, heart attacks, and hospitalization due to heart failure in adults with chronic kidney disease associated with type II diabetes mellitus. Patients with kidney disease, would originally be given [spironolactone] or [eplerenone] to antagonize the mineraclocorticoid receptor. Spironolactone has low selectivity and affinity for the receptor; it dissociates quickly and can also have effects at the androgen, progesterone, and glucocorticoid receptors. Eplerenone is more selective and has longer lasting effects. More selective nonsteroidal mineralocorticoid antagonists such as [apararenone], [esaxerenone], and finerenone were later developed. So far, finerenone is the only nonsteroidal mineralocorticoid receptor antagonist to be FDA approved. Finerenone was granted FDA approval on 9 July 2021.

Finerenone Manufacturers

A Finerenone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Finerenone, including repackagers and relabelers. The FDA regulates Finerenone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Finerenone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Finerenone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Finerenone Suppliers

A Finerenone supplier is an individual or a company that provides Finerenone active pharmaceutical ingredient (API) or Finerenone finished formulations upon request. The Finerenone suppliers may include Finerenone API manufacturers, exporters, distributors and traders.

click here to find a list of Finerenone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Finerenone USDMF

A Finerenone DMF (Drug Master File) is a document detailing the whole manufacturing process of Finerenone active pharmaceutical ingredient (API) in detail. Different forms of Finerenone DMFs exist exist since differing nations have different regulations, such as Finerenone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Finerenone DMF submitted to regulatory agencies in the US is known as a USDMF. Finerenone USDMF includes data on Finerenone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Finerenone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Finerenone suppliers with USDMF on PharmaCompass.

Finerenone KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Finerenone Drug Master File in Korea (Finerenone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Finerenone. The MFDS reviews the Finerenone KDMF as part of the drug registration process and uses the information provided in the Finerenone KDMF to evaluate the safety and efficacy of the drug.

After submitting a Finerenone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Finerenone API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Finerenone suppliers with KDMF on PharmaCompass.

Finerenone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Finerenone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Finerenone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Finerenone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Finerenone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Finerenone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Finerenone suppliers with NDC on PharmaCompass.

Finerenone GMP

Finerenone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Finerenone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Finerenone GMP manufacturer or Finerenone GMP API supplier for your needs.

Finerenone CoA

A Finerenone CoA (Certificate of Analysis) is a formal document that attests to Finerenone's compliance with Finerenone specifications and serves as a tool for batch-level quality control.

Finerenone CoA mostly includes findings from lab analyses of a specific batch. For each Finerenone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Finerenone may be tested according to a variety of international standards, such as European Pharmacopoeia (Finerenone EP), Finerenone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Finerenone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty